Please note, this OEL/ADE monograph also applies to butamirate base (CAS RN 18109-80-3). Butamirate citrate is a cough suppressant indicated for use in non-productive cough. Butamirate citrate exerts antitussive action and is not chemically or pharmacologically related to the opioid alkaloids. It is considered that butamirate citrate is a centrally acting drug, but the exact mechanism of action is not known. It exerts non-specific anticholinergic and bronchospasmolytic effects, thereby improving respiratory function.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Butamirate Citrate, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’s OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.